home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

2-day In-person Seminar on “Why is FDA at my Facility, and What do I do During an Inspection” at Washington DC

 
  September 26, 2013  
     
 
GlobalCompliancePanel, Washington DC
2013-10-10


Course Outline:

Day 1 - Agenda

Lecture 1: How a firm should prepare for an FDA inspection 
Lecture 2: Ways to train employees in view of the inspection 
Lecture 3: How to ensure that required documentation is in place 
Lecture 4: How to interact with the investigator-DO's and DON'T's 
Lecture 5: What companies should do when the inspection ends 
Lecture 6: How to reply to 483's and warning letters 
Lecture 7: Legal implications of non-compliance 
Lecture 8: Post inspection actions 

Day 2 – Agenda

Lecture 1: Why inspections are conducted and by what statutory authority 
Lecture 2: The emphasis on systems-based inspections...and the IOM and other crucial FDA reference documents 
Lecture 3: What is subject to FDA purview and what's off-limits 
Lecture 4: Understand and apply the do's and don'ts and comprehend that preparation is the key to success 
Lecture 5: What are the prohibited "Acts" and the enforcement categories that you need to deal with 
Lecture 6: What you need to know and do to prepare for, during and even after the inspection...and why your inspection response team is key 
Lecture 7: The company's Inspection Plan (SOP) can make or break the inspection depending on how to use it and training your personnel 
Lecture 8: How to respond to findings and facilitating the documentation and remediation process...and reaching final closure 
Lecture 9: Define clear responsibilities, roles and goals for personnel involved in SOP development 

 

 
 
Organized by: GlobalCompliancePanel
Invited Speakers:

Overview:

Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer. This presentation will review and emphasize the do's and don'ts and cardinal rules as to interviewing, how to respond, reviewing documentation, etiquette, use of certain words, body language, responding to questions/requests, etc., and certainly replying to 483's and Warning Letters. Emphasis is placed on the company's SOP on dealing with inspectors and knowing how to be prepared, proactive...and being able to defend and justify... and what it takes to achieve a favorable outcome. This seminar provides background and understanding of the role played by the Agency, its administrative and enforcement powers. It takes the participant step by step through the entire inspection process and describes various types of inspections. 

Who Will Benefit:

This seminar will provide valuable assistance and guidance to all regulated companies that are preparing for FDA inspections.

The employees who will benefit include:

·         All levels of Management for all departments

·         QA/QC/Compliance/Regulatory Affairs

·         Information Technology/Marketing & Sales

·         Engineering/Technical Services/Validation

·         Consultants

·         Operations and Manufacturing

 
Deadline for Abstracts: 2013-10-08
 
Registration:

For More Details: http://www.globalcompliancepanel.com/control/FDA-my-facility

E-mail: support@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.